Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBITDA Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBITDA Margin for 2 consecutive years, with 5603.19% as the latest value for Q1 2024.

  • On a quarterly basis, EBITDA Margin changed N/A to 5603.19% in Q1 2024 year-over-year; TTM through Dec 2024 was 26219.12%, a N/A change, with the full-year FY2024 number at 26219.12%, down 2613283.0% from a year prior.
  • EBITDA Margin was 5603.19% for Q1 2024 at Artiva Biotherapeutics, down from 671.59% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 671.59% in Q4 2023 to a low of 5603.19% in Q1 2024.